178 related articles for article (PubMed ID: 37828626)
21. Development and validation of a radiomics-based nomogram for the preoperative prediction of microsatellite instability in colorectal cancer.
Ying M; Pan J; Lu G; Zhou S; Fu J; Wang Q; Wang L; Hu B; Wei Y; Shen J
BMC Cancer; 2022 May; 22(1):524. PubMed ID: 35534797
[TBL] [Abstract][Full Text] [Related]
22. Response to Chemotherapy and Prognosis in Metastatic Colorectal Cancer With DNA Deficient Mismatch Repair.
Alex AK; Siqueira S; Coudry R; Santos J; Alves M; Hoff PM; Riechelmann RP
Clin Colorectal Cancer; 2017 Sep; 16(3):228-239. PubMed ID: 28063788
[TBL] [Abstract][Full Text] [Related]
23. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.
Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T
Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842
[TBL] [Abstract][Full Text] [Related]
24. Concordance between microsatellite instability and mismatch repair protein expression in colorectal cancer and their clinicopathological characteristics: a retrospective analysis of 502 cases.
Ye M; Ru G; Yuan H; Qian L; He X; Li S
Front Oncol; 2023; 13():1178772. PubMed ID: 37427134
[TBL] [Abstract][Full Text] [Related]
25. Heterogeneity of Mismatch Repair Status and Microsatellite Instability between Primary Tumour and Metastasis and Its Implications for Immunotherapy in Colorectal Cancers.
Evrard C; Messina S; Sefrioui D; Frouin É; Auriault ML; Chautard R; Zaanan A; Jaffrelot M; De La Fouchardière C; Aparicio T; Coriat R; Godet J; Silvain C; Randrian V; Sabourin JC; Guimbaud R; Miquelestorena-Standley E; Lecomte T; Moulin V; Karayan-Tapon L; Tachon G; Tougeron D
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457245
[TBL] [Abstract][Full Text] [Related]
26. An Insight into Deficient Mismatch Repair Colorectal Cancer Screening in a Romanian Population-A Bi-Institutional Pilot Study.
Lungulescu C; Croitoru VM; Volovat SR; Cazacu IM; Turcu-Stiolica A; Gheonea DI; Sur D; Lungulescu CV
Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441055
[No Abstract] [Full Text] [Related]
27. The efficiency of neoadjuvant chemotherapy in colon cancer with mismatch repair deficiency.
Yunlong W; Tongtong L; Hua Z
Cancer Med; 2023 Feb; 12(3):2440-2452. PubMed ID: 35904113
[TBL] [Abstract][Full Text] [Related]
28. Impact of mismatch repair or microsatellite status on the prognosis and efficacy to chemotherapy in metastatic colorectal cancer patients: A bi-institutional, propensity score-matched study.
Yao YC; Jin Y; Lei XF; Wang ZX; Zhang DS; Wang FH; Li YH; Xu RH; Wang F
J Cancer; 2022; 13(9):2912-2921. PubMed ID: 35912009
[No Abstract] [Full Text] [Related]
29. Comparison of Mismatch Repair Status Between Primary and Matched Metastatic Sites in Patients With Colorectal Cancer.
He WZ; Hu WM; Wang F; Rong YM; Yang L; Xie QK; Yang YZ; Jiang C; Qiu HJ; Lu JB; Zhang B; Ding PR; Xia XJ; Shao JY; Xia LP
J Natl Compr Canc Netw; 2019 Oct; 17(10):1174-1183. PubMed ID: 31590148
[TBL] [Abstract][Full Text] [Related]
30. Tumor Budding
Karlberg M; Stenstedt K; Hallström M; Ragnhammar P; Lenander C; Edler D
Anticancer Res; 2018 Aug; 38(8):4713-4721. PubMed ID: 30061240
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of Concordance Between Deficient Mismatch Repair and Microsatellite Instability Testing and Their Association with Clinicopathological Features in Colorectal Cancer.
Bai H; Wang R; Cheng W; Shen Y; Li H; Xia W; Ding Z; Zhang Y
Cancer Manag Res; 2020; 12():2863-2873. PubMed ID: 32425600
[TBL] [Abstract][Full Text] [Related]
32. Histomorphological and molecular genetic characterization of different intratumoral regions and matched metastatic lymph nodes of colorectal cancer with heterogenous mismatch repair protein expression.
Zhang J; Zhang X; Wang Q; Xu YY; Yao QL; Huang D; Sheng WQ; Zhu XL; Zhou XY; Bai QM
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3423-3434. PubMed ID: 35939113
[TBL] [Abstract][Full Text] [Related]
33. Mismatch Repair Deficient (dMMR) Colorectal Carcinoma in a Pakistani Cohort: Association With Clinical and Pathological Parameters.
Hashmi AA; Bukhari U; Rizwan R; Faisal F; Kumar R; Malik UA; Zia S; Khan AR; Sham S; Irfan M
Cureus; 2023 Aug; 15(8):e42781. PubMed ID: 37664303
[TBL] [Abstract][Full Text] [Related]
34. [Association of status of mismatch repair protein expression and EB virus infection with clinicopathological parameters in 886 gastric adenocarcinoma patients].
Liu Y; Zang FL; Qiu ZQ; Guo YH; Luo Y; Sun L; Zhao S; Shao B; Liang H; Sun Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):440-448. PubMed ID: 34000774
[No Abstract] [Full Text] [Related]
35. The risk of developing a mismatch repair deficient colorectal cancer after undergoing cholecystectomy.
Halldorsson MO; Hauptmann M; Snaebjornsson P; Haraldsdóttir KH; Aspelund T; Gudmundsson EF; Gudnason V; Jonasson JG; Haraldsdottir S
Scand J Gastroenterol; 2018 Aug; 53(8):972-975. PubMed ID: 30010450
[TBL] [Abstract][Full Text] [Related]
36. Comparison of immunological characteristics between paired mismatch repair-proficient and -deficient colorectal cancer patients.
Liu SS; Yang YZ; Jiang C; Quan Q; Xie QK; Wang XP; He WZ; Rong YM; Chen P; Yang Q; Yang L; Zhang B; Xia XJ; Kong PF; Xia LP
J Transl Med; 2018 Jul; 16(1):195. PubMed ID: 30005666
[TBL] [Abstract][Full Text] [Related]
37. Relation between mismatch repair status, chemoresponse, survival and anatomic location in gastroesophageal adenocarcinoma.
Evaristo G; Katz A; Ramírez-GarcíaLuna JL; Issac MSM; Sangwan V; Thai DV; Bertos N; Guiot MC; Camilleri-Broët S; Marcus V; Mueller C; Cools-Lartigue J; Fiset PO; Ferri LE
Can J Surg; 2023; 66(1):E79-E87. PubMed ID: 36792128
[TBL] [Abstract][Full Text] [Related]
38. Synchronous and metachronous primary colorectal cancers with concordant and discordant mismatch repair status.
Carlin L; Paudice M; Ingaliso M; Pigozzi S; Trevisan L; Sciallero S; Pastorino A; Piol N; Grillo F; Mastracci L
Hum Pathol; 2023 Nov; 141():54-63. PubMed ID: 37742947
[TBL] [Abstract][Full Text] [Related]
39. CT-based deep learning model for the prediction of DNA mismatch repair deficient colorectal cancer: a diagnostic study.
Cao W; Hu H; Guo J; Qin Q; Lian Y; Li J; Wu Q; Chen J; Wang X; Deng Y
J Transl Med; 2023 Mar; 21(1):214. PubMed ID: 36949511
[TBL] [Abstract][Full Text] [Related]
40. Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes.
Williams DS; Mouradov D; Jorissen RN; Newman MR; Amini E; Nickless DK; Teague JA; Fang CG; Palmieri M; Parsons MJ; Sakthianandeswaren A; Li S; Ward RL; Hawkins NJ; Faragher I; Jones IT; Gibbs P; Sieber OM
Gut; 2019 Mar; 68(3):465-474. PubMed ID: 29382774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]